Cargando…

Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis

Granulomatosis with Polyangiitis (GPA) is a rare systemic anti neutrophil cytoplasmic antibody (ANCA-) associated granulomatous vasculitis of the small and medium sized blood vessels. Diffuse alveolar hemorrhage (DAH) is a rare life-threatening complication of GPA. In our patient, cyclophosphamide w...

Descripción completa

Detalles Bibliográficos
Autores principales: Powers, Braden, Uppalapati, Aditya, Gogineni, Sindhura, Jamkhana, Zafar Akram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010015/
https://www.ncbi.nlm.nih.gov/pubmed/24829812
http://dx.doi.org/10.1155/2013/123134
_version_ 1782479824234741760
author Powers, Braden
Uppalapati, Aditya
Gogineni, Sindhura
Jamkhana, Zafar Akram
author_facet Powers, Braden
Uppalapati, Aditya
Gogineni, Sindhura
Jamkhana, Zafar Akram
author_sort Powers, Braden
collection PubMed
description Granulomatosis with Polyangiitis (GPA) is a rare systemic anti neutrophil cytoplasmic antibody (ANCA-) associated granulomatous vasculitis of the small and medium sized blood vessels. Diffuse alveolar hemorrhage (DAH) is a rare life-threatening complication of GPA. In our patient, cyclophosphamide was held secondary to complications of acute kidney injury, hematuria, and concern for a possible hemorrhagic cystitis. However, during the workup for hematuria the patient acutely developed respiratory failure and was found to have DAH. The patient was initially supported with mechanical ventilation volume control mode, steroids, and plasma exchange. With no improvement of oxygenation, the mode of ventilation was changed to airway pressure release ventilation (APRV) and the patient was started on rituximab. The patient clinically improved over the next few days, was able to be extubated, and was transferred out of the intensive care unit.
format Online
Article
Text
id pubmed-4010015
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40100152014-05-14 Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis Powers, Braden Uppalapati, Aditya Gogineni, Sindhura Jamkhana, Zafar Akram Case Rep Crit Care Case Report Granulomatosis with Polyangiitis (GPA) is a rare systemic anti neutrophil cytoplasmic antibody (ANCA-) associated granulomatous vasculitis of the small and medium sized blood vessels. Diffuse alveolar hemorrhage (DAH) is a rare life-threatening complication of GPA. In our patient, cyclophosphamide was held secondary to complications of acute kidney injury, hematuria, and concern for a possible hemorrhagic cystitis. However, during the workup for hematuria the patient acutely developed respiratory failure and was found to have DAH. The patient was initially supported with mechanical ventilation volume control mode, steroids, and plasma exchange. With no improvement of oxygenation, the mode of ventilation was changed to airway pressure release ventilation (APRV) and the patient was started on rituximab. The patient clinically improved over the next few days, was able to be extubated, and was transferred out of the intensive care unit. Hindawi Publishing Corporation 2013 2013-02-14 /pmc/articles/PMC4010015/ /pubmed/24829812 http://dx.doi.org/10.1155/2013/123134 Text en Copyright © 2013 Braden Powers et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Powers, Braden
Uppalapati, Aditya
Gogineni, Sindhura
Jamkhana, Zafar Akram
Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis
title Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis
title_full Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis
title_fullStr Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis
title_full_unstemmed Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis
title_short Rituximab—A Drug with Many Facets and Cures: A Treatment for Acute Refractory Hypoxemic Respiratory Failure Secondary to Severe Granulomatosis with Polyangiitis
title_sort rituximab—a drug with many facets and cures: a treatment for acute refractory hypoxemic respiratory failure secondary to severe granulomatosis with polyangiitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010015/
https://www.ncbi.nlm.nih.gov/pubmed/24829812
http://dx.doi.org/10.1155/2013/123134
work_keys_str_mv AT powersbraden rituximabadrugwithmanyfacetsandcuresatreatmentforacuterefractoryhypoxemicrespiratoryfailuresecondarytoseveregranulomatosiswithpolyangiitis
AT uppalapatiaditya rituximabadrugwithmanyfacetsandcuresatreatmentforacuterefractoryhypoxemicrespiratoryfailuresecondarytoseveregranulomatosiswithpolyangiitis
AT goginenisindhura rituximabadrugwithmanyfacetsandcuresatreatmentforacuterefractoryhypoxemicrespiratoryfailuresecondarytoseveregranulomatosiswithpolyangiitis
AT jamkhanazafarakram rituximabadrugwithmanyfacetsandcuresatreatmentforacuterefractoryhypoxemicrespiratoryfailuresecondarytoseveregranulomatosiswithpolyangiitis